More on the financial links between the Center for Practical Bioethics, AJOB and Purdue Pharma, the manufacturer of Oxycontin, this time from the Kansas City Star:
"In 2010, Christopher and other experts published an article in The
American Journal of Bioethics that raised concerns about the growing use
of “pain contracts” between physicians and patients receiving pain
medications. The contracts frequently call for urine screenings, require
patients to use a single pharmacy and limit prescription refills.
Patients who don’t abide by the terms may be dropped from treatment."